Indiana 2024 Regular Session

Indiana House Bill HB1426

Introduced
1/16/24  
Refer
1/16/24  
Report Pass
1/30/24  
Engrossed
2/6/24  
Refer
2/12/24  
Refer
2/22/24  
Report Pass
2/29/24  
Enrolled
3/5/24  
Passed
3/12/24  
Chaptered
3/12/24  

Caption

Long acting reversible contraceptives.

Impact

The introduction of HB 1426 is aimed at improving reproductive health options for women, particularly in low-income demographics. By ensuring that Medicaid recipients have access to long-acting contraceptives directly after childbirth, the bill seeks to reduce unintended pregnancies and empower women with choices regarding their reproductive health. The provision for hospitals to receive additional reimbursement for these services reinforces the state’s commitment to supporting maternal health care across Indiana.

Summary

House Bill 1426 mandates that Indiana hospitals providing maternity care and licensed under the state's public health laws must offer long-acting reversible subdermal contraceptives to eligible women postpartum, specifically targeting those who are Medicaid recipients or eligible for Medicaid. The bill stipulates that this option must be available unless deemed medically contraindicated. The legislation is set to enact provisions effective July 1, 2024, and include financial mechanisms for reimbursement to hospitals that comply with these requirements.

Sentiment

The overall sentiment surrounding HB 1426 appears to be largely supportive, especially among reproductive health advocates who see it as a progressive step towards enhancing women's health care. Supporters argue that the bill acknowledges the socio-economic barriers many women face in accessing reproductive health services. However, some opposition exists, as critics express concerns about the potential moral implications and the prioritization of contraceptive access in hospital settings.

Contention

Notable points of contention may arise from the exemption clause allowing hospitals with faith-based objections to opt out of the requirement. This could lead to disparities in access to contraceptive options based on the type of hospital. Furthermore, while the bill is viewed positively for its intent to provide health care options, the sunset provision that expires on June 30, 2025, raises questions about the long-term commitment of the state to support such initiatives.

Companion Bills

No companion bills found.

Previously Filed As

IN SB0266

Long acting reversible contraceptives.

IN SB0252

Long acting reversible contraceptives.

IN HB1568

Prescription for hormonal contraceptives.

IN HB1224

Pharmacist contraceptive prescriptions.

IN SB0153

Pharmacist contraceptive prescriptions.

IN SB0206

Pharmacist contraceptive prescriptions.

IN HB1461

Long term services.

IN HB1433

Reimbursement for prosthetic and orthotic devices.

IN HB1313

Medicaid reimbursement for children's hospitals.

IN HB1514

Health matters.

Similar Bills

No similar bills found.